Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > AGM Dec 30

<< Previous

Bullboard Posts

Next >>

Comment by Pareto8020on Oct 31, 2022 2:36pm

113 Views

Post# 35060841

RE:RE:RE:AGM Dec 30

I recall that as well - could be dj vu all over again.

Perhaps he isn't going to be able to close the pet deal by year end like he indicated (shocker I know) or is trying to give himself enough wiggle room to get it done by the AGM.

Or it could be his complete farcical time as CEO and driving the stock price and volume into the ground after what was supposed to be a watershed deal for Sirona and him not wanting to endure the ire of long suffering shareholders. Or he could just be an antisocial a$$whole - who knows with this CEO anymore.

<< Previous

Bullboard Posts

Next >>

DRI Healthcare stock drops 28% after executive changes